Artificial Intelligence Identifies Breast Cancer Missed by Initial Screening

An individual has expressed profound gratitude towards artificial intelligence for detecting her breast cancer, a diagnosis that followed an initial routine scan which had indicated no abnormalities. Sheila Tooth, a resident of Littlehampton, West Sussex, underwent a mammogram at University Hospitals Sussex NHS Foundation Trust (UHSussex). This trust employs AI technology to enhance breast cancer screening processes, specifically to identify cancers that human “readers” might overlook. The cancerous cells in the 68-year-old patient were nearly imperceptible and had gone undetected prior to their discovery by AI. “I’m deeply grateful for it to have been caught so early,” she stated. “When I talk to friends, we just can’t believe this AI can detect what the human eye can’t always see. I just feel so lucky.“Being 68, this may have been my last mammogram, so my early cancer might have developed into invasive cancer in my 70s.” UHSussex was among 15 trusts nationwide that took part in a project focused on utilizing AI for mammogram analysis. Over the course of the two-month initiative, AI technology was used to review more than 12,000 mammograms previously classified as “normal.” According to UHSussex, the AI software recommended that slightly less than 10% of these mammograms undergo a re-reading by a clinical panel to pinpoint any potential cancers missed during the initial screening process. Subsequent to this additional review, 11 women were recalled for further investigation, and five of them were diagnosed with breast cancer. Dr. Olga Strukowska, a consultant radiologist and director of the West Sussex breast screening programme, characterized AI screening as “exciting.” She stated, “The earlier and more accurately we detect cancer, the better the chance our patients will have a positive outcome.” She continued, “That’s why this is so exciting. Using AI increases accuracy while reducing the number of missed cancers and lowering false positives. “It empowers screening services to deliver confident, accurate, timely results through deep learning technology that works with radiologists and promotes high-quality standards of care for our patients.” Annually in Sussex, approximately 650 women receive a breast cancer diagnosis subsequent to their screening. The established programme extends invitations for screening every three years to women between the ages of 50 and 71. UHSussex intends to participate in a national randomized controlled trial, marking the subsequent stage of integrating AI into breast screening procedures.